Create Free Account

By creating account you will get access to hot stocks & personalised emails

Cardiex Ltd

Healthcare AU CDX

0.06AUD
0.005(9.09%)

Last update at 2024-05-20T04:05:00Z

Day Range

0.060.07
LowHigh

52 Week Range

0.040.20
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -19.06330M -11.38338M -5.54560M -3.32043M -2.97928M
Minority interest - - - - -
Net income -19.06330M -11.38338M -5.54560M -3.32043M -3.03507M
Selling general administrative 14.97M 11.85M 8.42M 6.62M 3.30M
Selling and marketing expenses 1.27M 1.54M 0.18M 0.43M 2.14M
Gross profit 3.70M 3.13M 4.10M 3.59M 3.10M
Reconciled depreciation - 0.22M 0.18M 0.21M 0.12M
Ebit -18.77507M -11.15544M -5.27721M -3.15569M -2.82404M
Ebitda -18.71278M -10.93664M -5.09478M -2.95045M -2.70752M
Depreciation and amortization 0.06M 0.22M 0.18M 0.21M 0.12M
Non operating income net other - - - - -
Operating income -15.35113M -12.66046M -4.86097M -3.66768M -2.82404M
Other operating expenses 24.66M 17.60M 10.66M 8.26M 7.87M
Interest expense 0.35M 0.23M 0.27M 0.16M 0.10M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Interest income 0.68M 0.43M 0.84M 0.13M 0.05M
Net interest income -0.09287M 0.20M -0.01189M -0.16474M 0.06M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.05M 1.28M 0.20M 1.16M 0.06M
Total revenue 4.60M 4.07M 5.00M 4.29M 3.91M
Total operating expenses 23.43M 15.99M 9.75M 7.95M 7.07M
Cost of revenue 0.91M 0.94M 0.91M 0.70M 0.80M
Total other income expense net 0.76M 1.05M -0.06616M 1.00M -0.15524M
Discontinued operations - - - - -
Net income from continuing ops -19.06330M -11.38338M -5.54560M -3.32043M -2.97928M
Net income applicable to common shares -19.06331M -11.38338M -5.54560M -3.32043M -2.97928M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 14.30M 12.38M 11.26M 10.68M 13.21M
Intangible assets 0.63M 0.32M 0.33M 0.06M 0.04M
Earning assets - - - - -
Other current assets 1.43M 1.57M 1.10M 0.75M 0.74M
Total liab 15.30M 5.77M 3.35M 4.80M 6.26M
Total stockholder equity -1.00077M 6.61M 7.91M 5.88M 6.95M
Deferred long term liab - 0.20M 0.22M - -
Other current liab 3.55M 0.59M 0.70M 0.50M 0.35M
Common stock 76.79M 67.55M 59.29M 53.13M 51.50M
Capital stock 76.79M 67.55M 59.29M 53.13M 51.50M
Retained earnings -83.92988M -65.23711M -54.46235M -49.21749M -46.16327M
Other liab 0.00616M 0.00182M 0.00022M - 0.02M
Good will - - - - -
Other assets 0.08M 0.08M 0.94M 5.02M 5.35M
Cash 0.72M 1.46M 3.67M 2.06M 4.98M
Cash and equivalents - - - - -
Total current liabilities 14.81M 5.12M 3.25M 3.64M 5.15M
Current deferred revenue 3.04M 0.88M 0.43M 1.52M 0.86M
Net debt 1.40M 0.61M -2.49663M 0.17M -0.44798M
Short term debt 1.63M 1.42M 1.04M 1.09M 3.45M
Short long term debt 1.46M 1.30M 0.99M 0.97M 3.35M
Short long term debt total 2.11M 2.07M 1.17M 2.24M 4.53M
Other stockholder equity 6.14M 0.37M -2.23778M 1.97M 1.61M
Property plant equipment 1.47M 1.07M 0.35M 0.57M 0.61M
Total current assets 11.61M 4.83M 9.30M 4.69M 6.96M
Long term investments 0.51M 4.60M 3.25M 5.30M 5.60M
Net tangible assets -1.63382M 5.92M 7.58M 5.82M 6.91M
Short term investments 5.56M 1.04M 1.54M 0.73M 0.73M
Net receivables 2.24M 0.81M 0.56M 0.82M 1.01M
Long term debt - - 0.00000M 0.96M 0.78M
Inventory 1.66M 1.06M 0.44M 0.26M 0.22M
Accounts payable 6.59M 2.22M 1.07M 0.54M 0.50M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 6.14M 3.93M 3.09M 1.97M 1.61M
Additional paid in capital - - - - -
Common stock total equity - - - 53.13M 51.50M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.08M 0.08M 0.03M 0.06M 5.60M
Deferred long term asset charges - - - - -
Non current assets total 2.69M 7.55M 1.97M 5.98M 6.26M
Capital lease obligations 0.65M 0.77M 0.18M 0.31M 0.40M
Long term debt total 0.48M 0.65M 0.11M 1.15M 1.08M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.08028M -0.43806M 0.36M -3.69911M -2.16565M
Change to liabilities 0.00000M 1.60M -0.74494M 0.85M -0.32059M
Total cashflows from investing activities -0.08028M -0.43806M 0.36M -3.69911M -2.16565M
Net borrowings 1.97M -0.01379M -0.59101M 1.53M 2.45M
Total cash from financing activities 11.35M 7.41M 5.29M 2.47M 6.75M
Change to operating activities - 0.12M 0.08M -0.02357M 0.23M
Net income -19.06330M -12.41424M -5.15970M -3.32043M -2.97928M
Change in cash -0.73927M -2.20967M 1.60M -2.91918M 2.24M
Begin period cash flow 1.46M 3.67M 2.06M 4.98M 2.74M
End period cash flow 0.72M 1.46M 3.67M 2.06M 4.98M
Total cash from operating activities -11.99635M -9.61738M -3.97279M -1.69885M -2.43894M
Issuance of capital stock 9.91M 7.60M 6.39M 1.00M 4.50M
Depreciation - 0.32M 0.25M 0.22M 0.12M
Other cashflows from investing activities - 0.00000M 0.72M -3.49022M -1.91639M
Dividends paid 2.98M 1.17M 0.18M 0.10M -
Change to inventory - -0.55039M -0.18537M -0.04075M 0.22M
Change to account receivables - -0.25782M -0.02667M -0.01595M -0.40205M
Sale purchase of stock -0.53591M -0.14881M -0.33341M -0.01324M -0.25194M
Other cashflows from financing activities 5.74M 2.19M -0.13123M 1.73M 2.50M
Change to netincome 7.07M 2.23M 2.17M 0.63M 0.85M
Capital expenditures 0.08M 0.44M 0.36M 0.21M 0.16M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - -0.80821M -0.21204M -0.05670M 0.00262M
Stock based compensation 2.07M 2.11M 1.40M 0.61M -
Other non cash items 5.00M 2.47M 0.93M 1.40M 2.86M
Free cash flow -12.07663M -10.05543M -4.33113M -1.90775M -2.59493M

Fundamentals

  • Previous Close 0.06
  • Market Cap17.65M
  • Volume50075
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-4.91044M
  • Revenue TTM14.16M
  • Revenue Per Share TTM0.10
  • Gross Profit TTM 4.79M
  • Diluted EPS TTM-0.06

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CDX
Cardiex Ltd		 0.005 9.09% 0.06 - - 1.54 1002.62 1.66 -2.4682
COH
Cochlear Ltd		 -6.03 1.83% 324.36 62.10 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 -0.02 0.96% 2.06 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd		 -0.26 1.33% 19.35 - - 104.23 14.98 95.15 -5.9152
EBR
Ebr Systems Inc CDR		 0.05 4.81% 1.09 - - - 5.68 - -7.482

Reports Covered

Stock Research & News

View All

Profile

CardieX Limited designs, manufactures, and markets medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that measures arterial health by collecting digital vascular biomarkers using novel sensors. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disorders; and develops and sells medical devices, digital solutions, and wearables for home health, decentralized clinical trials, and remote patient monitoring. It sells its cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Cardiex Ltd

55 Lime Street, Sydney, NSW, Australia, 2000

Key Executives

Name Title Year Born
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD Co-Founder & Exec. Chairman 1964
Mr. Craig R. Cooper BEC, L.L.B. Co-Founder, CEO, MD & Exec. Director NA
Mr. Jarrod Travers White B.Bus, C.A., CA, CTA CFO, Joint Company Sec. & Exec. Director NA
Steve Braaten Operations Director NA
Carol Targos Accounts Mang. NA
Ahmad Qasem Chief Science & Research Officer NA
Mr. Antony Sloan Global Head of Marketing & Communications NA
Mr. ZiHan Lin VP of Corp. & Bus. Devel. NA
Ric Ruffhead Director of Sales NA
Mr. Douglas T. Kurschinski Exec. VP & Head of Global Sales for AtCor Medical Division NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.